Batch Notification Number |
BN-OL-2022-11-28-6133
|
FDA Registered Product/Generic Name |
Cefuroxime (as Axetil)
|
Brand Name |
CEFUSAPH-125
|
Dosage Strength |
125 mg/ 5 mL
|
Dosage Form |
Powder for Oral Suspension
|
Registration Number |
DRP-8291
|
Batch Number |
NPCADS125-04
|
Lot Number |
N/A
|
Product Expiration Date |
Jan. 2025
|
Issuance Date |
06 December 2022
|